BioMarin Pharmaceutical Inc. (0HNC.L)

USD 66.73

(-0.75%)

Eps Summary of BioMarin Pharmaceutical Inc.

  • BioMarin Pharmaceutical Inc.'s latest annual eps in 2023 was 0.89 USD , up 17.11% from previous year.
  • BioMarin Pharmaceutical Inc.'s latest quarterly eps in 2024 Q2 was 0.56 USD , up 19.15% from previous quarter.
  • BioMarin Pharmaceutical Inc. reported an annual eps of 0.76 USD in 2022, up 317.14% from previous year.
  • BioMarin Pharmaceutical Inc. reported an annual eps of -0.35 USD in 2021, down -107.37% from previous year.
  • BioMarin Pharmaceutical Inc. reported a quarterly eps of 0.47 USD for 2024 Q1, up 327.27% from previous quarter.
  • BioMarin Pharmaceutical Inc. reported a quarterly eps of 557.06 USD for 2024 Q3, up 1.79% from previous quarter.

Annual Eps Chart of BioMarin Pharmaceutical Inc. (2023 - 1998)

Historical Annual Eps of BioMarin Pharmaceutical Inc. (2023 - 1998)

Year Eps Eps Growth
2023 0.89 USD 17.11%
2022 0.76 USD 317.14%
2021 -0.35 USD -107.37%
2020 4.75 USD 3753.85%
2019 -0.13 USD 70.45%
2018 -0.44 USD 34.33%
2017 -0.67 USD 82.37%
2016 -3.80 USD -255.14%
2015 -1.07 USD -16.3%
2014 -0.92 USD 28.13%
2013 -1.28 USD -34.74%
2012 -0.95 USD -97.92%
2011 -0.48 USD -124.12%
2010 1.99 USD 40712.24%
2009 -0.00 USD -101.58%
2008 0.31 USD 293.75%
2007 -0.16 USD 52.94%
2006 -0.34 USD 68.52%
2005 -1.08 USD 62.89%
2004 -2.91 USD -138.52%
2003 -1.22 USD 15.86%
2002 -1.45 USD 12.12%
2001 -1.65 USD -58.65%
2000 -1.04 USD -10.64%
1999 -0.94 USD -70.91%
1998 -0.55 USD 0.0%

Peer Eps Comparison of BioMarin Pharmaceutical Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 144.059%
Dynavax Technologies Corporation -0.05 USD 1894.355%
Supernus Pharmaceuticals, Inc. 0.02 USD -3592.946%
Perrigo Company plc -0.09 USD 1047.817%
Illumina, Inc. -7.35 USD 112.109%
Thermo Fisher Scientific Inc. 15.53 USD 94.269%
Iovance Biotherapeutics, Inc. -1.89 USD 147.09%
Walgreens Boots Alliance, Inc. -10.01 USD 108.891%
IQVIA Holdings Inc. 7.39 USD 87.957%
Heron Therapeutics, Inc. -0.80 USD 211.25%
Regeneron Pharmaceuticals, Inc. 37.05 USD 97.598%
Unity Biotechnology, Inc. -2.70 USD 132.963%
Waters Corporation 10.87 USD 91.812%
Biogen Inc. 8.02 USD 88.903%
Sangamo Therapeutics, Inc. -1.48 USD 160.135%
Evolus, Inc. -1.08 USD 182.407%
Adicet Bio, Inc. -3.31 USD 126.888%
Cara Therapeutics, Inc. -2.19 USD 140.639%
bluebird bio, Inc. -1.93 USD 146.114%
Esperion Therapeutics, Inc. -2.03 USD 143.842%
FibroGen, Inc. -2.92 USD 130.479%
Agilent Technologies, Inc. 4.22 USD 78.91%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 108.632%
Homology Medicines, Inc. -7.41 USD 112.011%
Geron Corporation -0.32 USD 378.125%
Alnylam Pharmaceuticals, Inc. -3.52 USD 125.284%
Amicus Therapeutics, Inc. -0.51 USD 274.51%
Myriad Genetics, Inc. -1.39 USD 164.029%
Viking Therapeutics, Inc. -0.91 USD 197.802%
Intellia Therapeutics, Inc. -5.42 USD 116.421%
Zoetis Inc. 5.08 USD 82.48%
Abeona Therapeutics Inc. -2.53 USD 135.178%
Mettler-Toledo International Inc. 36.10 USD 97.535%
Vertex Pharmaceuticals Incorporated 14.05 USD 93.665%
Kala Pharmaceuticals, Inc. -17.35 USD 105.13%
Ionis Pharmaceuticals, Inc. -2.56 USD 134.766%
Atara Biotherapeutics, Inc. -65.18 USD 101.365%
Verastem, Inc. -3.96 USD 122.475%
Nektar Therapeutics -1.45 USD 161.379%
Axsome Therapeutics, Inc. -5.27 USD 116.888%
Aclaris Therapeutics, Inc. -1.27 USD 170.079%
Sarepta Therapeutics, Inc. -5.80 USD 115.345%
OPKO Health, Inc. -0.25 USD 456.0%
Exelixis, Inc. 0.65 USD -36.923%
Neurocrine Biosciences, Inc. 2.56 USD 65.234%
Corcept Therapeutics Incorporated 1.02 USD 12.745%
Anavex Life Sciences Corp. -0.60 USD 248.333%
uniQure N.V. -6.47 USD 113.756%
Imunon, Inc. -2.16 USD 141.204%
Blueprint Medicines Corporation -8.37 USD 110.633%
Insmed Incorporated -5.34 USD 116.667%
Halozyme Therapeutics, Inc. 2.13 USD 58.216%
Agios Pharmaceuticals, Inc. -6.33 USD 114.06%
TG Therapeutics, Inc. 0.09 USD -896.641%
Incyte Corporation 2.67 USD 66.667%
Emergent BioSolutions Inc. -14.85 USD 105.993%